Arkema will increase fluoropolymer (Kynar® PVDF) capacity at its Calvert City plant in the United States by some 20%. The expansion is fueled by strong demand in the new energies and water management markets as well as in more traditional applications (chemical process industry and high performance cables). In line with the strategy presented at its recent Capital Markets Day, this investment, scheduled to start mid-2018, further supports Arkema’s ambition to accelerate the development of its advanced materials, one of the key pillars of its future growth.
Eager to sustain its customers’ strong growth, in particular in automotive, 3D-printing, and in consumer goods markets such as sports and electronics, Arkema announces an investment plan of some 300 million euros over five years in the biosourced polyamide 11 chain. This major investment will enable the Group to increase by 50% its polyamide 11 global production capacities. The project falls in line with Arkema’s strategy to speed up its development in advanced materials, one of the key pillars of its future growth, sustained by a unique portfolio of innovations around the main sustainable development trends.
Arkema today announces a project to double its methyl mercaptan production capacity at its Kerteh site in Malaysia to support the strong growth of the animal feed, petrochemical and refining markets in Asia and to strengthen its world leading position in high value added sulfur derivatives.
To support the growth of Sartomer, the world leader in specialty photocure resins, Arkema announces a project to expand by over 30% production capacity at its Nansha facility in China. This new production line will in particular help meet strong customer demand in Asia in the electronics, 3D-printing and inkjet printing cutting-edge markets.
Presenting its long-term growth strategy at its Capital Markets Day on 11 July, Arkema affirms its determination to speed up its development in specialties, which should account for more than 80% of the Group’s sales by 2023. Confident to achieve its 1.3 billion euro EBITDA target in 2017 and in line with its objectives set out for 2020, Arkema announces ambitious financial objectives for 2023 supported by the announcement of several major investment projects in Asia, its innovation drive to address main societal challenges, and its bolt-on acquisition strategy in adhesives.
Arkema files a new complaint with the European Commission against Honeywell for abuse of dominant position with respect to patents covering the use of the refrigerant 1234yf in car air conditioning systems.
Arkema announces the acquisition by Bostik of CMP Specialty Products, the flooring and floor preparation business of US based specialist CGM. This business, which generated U$15 million sales in 2016, offers strong synergies with Bostik. This acquisition fits perfectly with Bostik's strategy to expand in the growing US construction market and to offer its customers a complete range of innovative solutions for the flooring market. This acquisition is also fully part of the Group strategy to accelerate its growth in specialty adhesives with bolt-on acquisitions.
Thierry Le Hénaff, Arkema Chairman and Chief Executive Officer, inaugurates the new specialty molecular sieve capacity at the Honfleur plant today. This new plant will enable the Group to support its customers’ growth in the refining and petrochemicals markets, in particular in Asia and the Middle East. This investment of some €60 million supports the development of the High Performance Materials segment, represents one of the Group’s growth drivers, and consolidates its n° 2 world ranking in molecular sieves.
Arkema has just successfully brought on stream new Kynar® PVDF capacities on its Changshu platform near Shanghai. With this 25% increase in its production capacities in China, Arkema, which runs PVDF production plants on 3 continents (Europe, North America and Asia), has consolidated its world leading position in PVDF.
Arkema announces that it filed its 2016 Reference Document with the French Autorité des marchés financiers (AMF) on 30 March 2017.
This document is available under the heading Investor Relations in section Financials / Annual reports of the Group’s website under the following link: www.finance.arkema.com
Arkema recently doubled the capacity of their Kepstan® PEKK (Poly-Ether-Ketone-Ketone) product line in France and confirms its future investment at its Mobile site (Alabama, United States) in a world-scale PEKK plant expected to come on stream in the second half of 2018.
Arkema is investing US$90 million on its Clear Lake Texas site to replace existing acrylic acid production units with modern facilities using the latest available technologies. Thus Arkema will position the Clear Lake site among the most competitive in North America while meeting growing demand in the region.
Arkema completed the acquisition of Den Braven, a leader in high performance sealants for insulation and construction in Europe, on 1st December. With this strong value-creating acquisition, Arkema confirms its long-term ambition for Bostik, and actively pursues the development of its High Performance Materials division.
Arkema announces a 25% Kynar® PVDF capacity increase on its Changshu platform near Shanghai. This project will help meet the strong demand, in particular in new energies and water treatment applications. This investment will support the Group’s ambition in Technical Polymers, and is part of its strategy to speed up the growth of its High Performance Materials division.
Arkema announced today plans to construct a new leading class polyester powder resin manufacturing facility, the first of its kind in India, on its existing resin platform in Navi Mumbai, Maharashtra. The project, which represents an investment of approximately $US 15M and is targeted for completion in 2018, includes a new manufacturing unit and a dedicated new laboratory to provide both application development and technical support. The new facility will support customers in the fast growing powder coating market.